ROCHESTER, N.Y., Feb. 21, 2014 /PRNewswire/ -- VirtualScopics,
Inc. (NASDAQ: VSCP), a leading provider of quantitative imaging,
today announced that before the market opens on Friday, March 7, 2014 it will release its fourth
quarter and full year 2013 financial results. VirtualScopics'
management will host a conference call that morning at 11:00 a.m. ET to provide a business update and
discuss the company's results for the quarter and year ended
December 31, 2013.
Interested participants should call 877-407-8035 when calling
within the United States or
+1 201 689 8035 when calling internationally. This call can
also be accessed at www.virtualscopics.com and will be available
for 30 days after the call.
About VirtualScopics, Inc.
VirtualScopics, Inc. is a
leading provider of imaging solutions to accelerate drug and
medical device development. VirtualScopics has developed a
robust software platform for analysis and modeling of both
structural and functional medical images. In combination with
VirtualScopics' industry-leading experience and expertise in
advanced imaging biomarker measurement, this platform provides a
uniquely clear window into the biological activity of drugs and
devices in clinical trial patients, allowing sponsors to make
better decisions faster. For more information about
VirtualScopics, visit www.virtualscopics.com.
Forward-Looking Statements
The statements contained in this press release that are not purely
historical are forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended and Section
21E of the Securities Exchange Act of 1934, as amended, and are
intended to be covered by the safe harbors created thereby. These
forward-looking statements include, but are not limited to,
statements regarding the backlog and new customer awards and/or
statements preceded by, followed by or that include the words
"believes," "could," "expects," "anticipates," "estimates,"
"intends," "plans," "projects," "seeks," or similar expressions.
Forward-looking statements deal with the Company's current plans,
intentions, beliefs and expectations. Investors are cautioned that
all forward-looking statements involve risks and uncertainties that
could cause actual results to differ materially from those in the
forward-looking statements. Many of these risks and
uncertainties are discussed in the Company's Annual Report on Form
10-K for the fiscal year ended December 31,
2012 filed with the Securities and Exchange Commission (the
"SEC"), and in any subsequent reports filed with the SEC,
all of which are available at the SEC's website at www.sec.gov.
These include without limitation: the risk of cancellation or delay
of customer contracts or specifically as it relates to awards of
contracts currently under negotiation, the risk that they may not
get signed. Other risks include the company's dependence on
its largest customers and risks of contract performance. All
forward-looking statements speak only as of the date of this press
release and the Company undertakes no obligation to update such
forward-looking statements.
CONTACTS:
Investor
Relations:
Nicole Schoenberg
FleishmanHillard
212-453-2445
nicole.schoenberg@fleishman.com
SOURCE VirtualScopics, Inc.